Triazolam: Clinical Trials

2 trials of Triazolam, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Terminated 1

Follow Triazolam: new trials by email Literature Review of Triazolam trials Research Report on Triazolam

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacovigilance in Gerontopsychiatric Patients
Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression
Phase 3TerminatedHannover Medical School4072015-01-012018-02-28
Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers
Gabapentin, Diphenhydramine citrate, Triazolam - Healthy
Phase 3CompletedPfizer's Upjohn has merged with Mylan to form Viatris Inc.592013-07-292021-02-21

Conditions studied

Anxiety Disorders (1)  ·  Dementia (1)  ·  Depression (1)  ·  Psychophysiologic Disorders (1)  ·  Schizophrenia (1)  ·  Sleep Initiation and Maintenance Disorders (1)

Sponsors

Hannover Medical School (1)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1)

Countries

Germany (1)  ·  United States (1)

Top investigators

Helge Frieling, Prof., MD (1)